United States· US:71655-578_cd0fd8d1-d716-4b80-ab41-1e524ed11072
Ebanga
A ansuvimab product containing ansuvimab, registered in United States by Emergent Manufacturing Operations Baltimore, LLC.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- Ansuvimab
- Manufacturer
- Emergent Manufacturing Operations Baltimore, LLC
- Country
- United States (US)
- ATC code
- J06BD04
- ATC class
- Ansuvimab
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- June 3, 2026
Packs & prices · 3
- ndc1171655578031 CARTON in 1 BOX (71655-578-03) / 36 VIAL, GLASS in 1 CARTON (71655-578-02) / 8 mL in 1 VIAL, GLASS (71655-578-01)
- ndc1171655578044 CARTON in 1 BOX (71655-578-04) / 36 VIAL, GLASS in 1 CARTON (71655-578-02) / 8 mL in 1 VIAL, GLASS (71655-578-01)
- ndc1171655578088 CARTON in 1 BOX (71655-578-08) / 36 VIAL, GLASS in 1 CARTON (71655-578-02) / 8 mL in 1 VIAL, GLASS (71655-578-01)
Regulatory notes
Same class
Other records under J06BD04
Ansuvimab, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f1f2e62c-3e22-4aa4-bf2b-7af2cebcb136 GET /v1/drugs/f1f2e62c-3e22-4aa4-bf2b-7af2cebcb136?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unii": {
"unii": "TG8IQ19NG2",
"rxcui": "2472152",
"inchikey": null,
"display_name": "ANSUVIMAB",
"substance_type": "protein",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "INTRAVENOUS",
"spl_meta": {
"de220c8f-ffcb-4522-a6a2-c7d6ce5de1b5": {
"match": "brand_token",
"title": "EBANGA (ANSUVIMAB) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [EMERGENT MANUFACTURING OPERATIONS BALTIMORE, LLC]",
"spl_version": "2",
"published_date": "2026-03-02"
}
},
"productid": "71655-578_cd0fd8d1-d716-4b80-ab41-1e524ed11072",
"productndc": "71655-578",
"dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "ANSUVIMAB",
"proprietary_name": "Ebanga",
"active_ingred_unit": "mg/8mL",
"application_number": "BLA761172",
"marketing_category": "BLA",
"nonproprietary_name": "Ansuvimab",
"start_marketing_date": "20201221",
"active_numerator_strength": "400"
}See everything about ansuvimab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.